Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "general transcription factor IIE, polypeptide 2, beta 34kDa pseudogene" (ENSG00000271457) refers to a pseudogene form associated with the gene GTF2E2, which encodes the beta subunit of general transcription factor IIE (TFIIE). TFIIE is an essential general transcription factor that is part of the RNA polymerase II preinitiation complex, required for mRNA synthesis and transcription initiation. However, because this specific entry is a pseudogene, it does not produce a functional protein product and is not considered a therapeutic or biological target. Pseudogenes are genomic sequences similar to known genes but typically nonfunctional due to mutations or lack of regulatory elements. There is no evidence supporting a therapeutic or biomarker role for this pseudogene, no interacting drugs, and no mechanisms of action or safety concerns relevant to drug targeting. If you seek information about the actual functional protein, it would be "General transcription factor IIE subunit 2" (gene: GTF2E2), whose protein product is part of the TFIIE complex essential to transcription initiation. Otherwise, as documented, this pseudogene is not a functional or druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIE pseudogene.